Vito Amodio - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Vito Amodio

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Cancer Cell|June 13, 2025

Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance in experimental cancer modelsPietro Paolo Vitiello, Benoit Rousseau, Rosaria Chilà, et al.

Science (New York, N.Y.)|November 9, 2019

Adaptive mutability of colorectal cancers in response to targeted therapiesMariangela Russo, Giovanni Crisafulli, Alberto Sogari, et al.

Cancer Discovery|April 21, 2026

Pharmacological inhibition of PMS2 induces MMR deficiency and response to immune checkpoint blockadeJulian Blagg, Philippe Riou, Alexia Hervieu, et al.

Cancer Discovery|May 21, 2020

EGFR Blockade Reverts Resistance to KRAS<sup>G12C</sup> Inhibition in Colorectal CancerVito Amodio, Rona Yaeger, Pamela Arcella, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Cancer Cell|June 13, 2025

Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance in experimental cancer modelsPietro Paolo Vitiello, Benoit Rousseau, Rosaria Chilà, et al.

Science (New York, N.Y.)|November 9, 2019

Adaptive mutability of colorectal cancers in response to targeted therapiesMariangela Russo, Giovanni Crisafulli, Alberto Sogari, et al.

Cancer Discovery|April 21, 2026

Pharmacological inhibition of PMS2 induces MMR deficiency and response to immune checkpoint blockadeJulian Blagg, Philippe Riou, Alexia Hervieu, et al.

Cancer Discovery|May 21, 2020

EGFR Blockade Reverts Resistance to KRAS<sup>G12C</sup> Inhibition in Colorectal CancerVito Amodio, Rona Yaeger, Pamela Arcella, et al.

Pageof 2